Provided by Tiger Trade Technology Pte. Ltd.

Ecopetrol SA

12.61
+0.19001.53%
Volume:2.00M
Turnover:24.92M
Market Cap:25.92B
PE:9.32
High:12.66
Open:12.40
Low:12.15
Close:12.42
52wk High:13.27
52wk Low:7.80
Shares:2.06B
Float Shares:233.42M
Volume Ratio:0.78
T/O Rate:0.86%
Dividend:0.99
Dividend Rate:7.86%
EPS(TTM):1.35
EPS(LYR):1.65
ROE:14.61%
ROA:6.46%
PB:1.33
PE(LYR):7.65

Loading ...

Press Release: Ecopetrol Announces Employee Elected to the Board of Directors on Slate Proposed by Government of Colombia as a Result of Voting Process

Dow Jones
·
Jan 16

Energy Stocks Break Their Slump. Which Charts Are Most Bullish? -- Barrons.com

Dow Jones
·
Jan 14

Rhythm Pharmaceuticals Announces Preliminary, Unaudited Fourth Quarter and Full Year 2025 Net Product Revenues and Upcoming Milestones

GlobeNewswire
·
Jan 09

Acrivon Therapeutics Announces Positive ACR-368 Phase 2b Endometrial Cancer Clinical Data with EU Expansion to Accelerate Enrollment, Initial ACR-2316 Clinical Data, and ACR-6840, its Next AP3-Enabled Development Candidate, Targeting CDK11

GlobeNewswire
·
Jan 08

Press Release: Renegotiations of Collective Bargaining Agreement

Dow Jones
·
Jan 08

Ecopetrol on Track for Longest Winning Streak Since April 2014 -- Data Talk

Dow Jones
·
Jan 06

Ecopetrol Says Trade Union to Start Renegotiation of Collective Bargaining Agreement

MT Newswires Live
·
Dec 29, 2025

Press Release: Ecopetrol Comments on Recent News Reports on a Potential Transaction

Dow Jones
·
Dec 29, 2025

Orthocell Submits Application to the British Standards Institution for Approval for Commercial Distribution of Nerve Repair Product, Shares Up 3%

MT Newswires Live
·
Dec 15, 2025

EU’s critical minerals strategy: €3 billion boost amid industry risks

Fastmarkets
·
Dec 12, 2025

Press Release: Decisions of the Board of Directors of Ecopetrol S.A.

Dow Jones
·
Dec 12, 2025

Rhythm Pharmaceuticals Announces Preliminary Data from Exploratory Phase 2 Trial that showed Setmelanotide Demonstrated Positive Efficacy Signal in Prader-Willi Syndrome

GlobeNewswire
·
Dec 11, 2025

Rhythm Pharmaceuticals to Announce Preliminary Data from Exploratory Phase 2 Trial Evaluating Setmelanotide in Prader-Willi Syndrome

GlobeNewswire
·
Dec 11, 2025

Ecopetrol Completes Negotiations With Grenergy for Potential Purchase of 7 Colombian Firms

MT Newswires Live
·
Dec 01, 2025

CStone Pharmaceuticals (SEHK:2616) Is Up 9.7% After EC Approval for Sugemalimab in Lung Cancer—Has The Bull Case Changed?

Simply Wall St.
·
Nov 29, 2025

Press Release: Updates from Ecopetrol S.A.'s Board of Directors

Dow Jones
·
Nov 28, 2025

Ecopetrol Details 2026 Investment Plan, Flags Cost Reductions

MT Newswires Live
·
Nov 28, 2025

Ecopetrol Appoints Angela Maria Robledo Gomez as Chairwoman

MT Newswires Live
·
Nov 28, 2025

EC Healthcare Swings to Fiscal H1 Loss as Revenue Declines 6%

MT Newswires Live
·
Nov 28, 2025

EC Healthcare Reports Decline in Interim Financial Results

TIPRANKS
·
Nov 28, 2025